Patient Services Vie For Bigger Share Of AIDS Funds

WASHINGTON-In the early 1980s, the lonely voices seeking funds for AIDS research were barely audible amid the din from the biomedical community as a whole. Over the past eight years, however, with the public also demanding that science step up its battle against the devastating-disease, the United States government has poured $5.5 billion into the AIDS epidemic, including $2.1 billion in the current year ending September 30. So far, about 40% of that total, nearly $2.2 billion, has been spent on

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

However, while the investment in basic research has added greatly to the store of knowledge about the AIDS virus, it has not yet led to an effective treatment: much less a cure. At the same time, more people are getting sick and living longer with the disease. And their plight threatens to control the hearts and. purse strings of society and drown out those who advocate the cause of science.

"AIDS is now a treatable disease," says Reed V. Tuckson, District of Columbia commissioner of health. "The implications of that are tremendous. Few health care systems are equipped to handle what's coming; nor is there much planning going on." Given the nation's limited resources, he adds, efforts to cope with the problem are "going to make Americans look like barbarians."

For scientists, the overwhelming need for care forebodes a potential squeeze on scarce resources. "We have a national consensus on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Elizabeth Pennisi

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Conceptual 3D image of DNA on a blue background.

Understanding the Nuts and Bolts of qPCR Assay Controls 

Bio-Rad
Takara Bio

Takara Bio USA Holdings, Inc. announces the acquisition of Curio Bioscience, adding spatial biology to its broad portfolio of single-cell omics solutions

Sapio Sciences

Sapio Sciences Announces Enhanced Capabilities for Chemistry, Immunogenicity, GMP and Molecular Biology

Biotium Logo

Biotium Unveils the Most Sensitive Stains for DNA or RNA with New EMBER™ Ultra Agarose Gel Kits